COVID 19 treatment through RNA interference

Auteurs

  • Yaseen Hussain College of Pharmaceutical Sciences, Soochow University, China
  • Amjad Hayat Khan Department of Allied Health Sciences, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Fazlullah Khan Faculty of pharmacy, Capital University of Science and Technology, Islamabad, Pakistan
  • Arbaz Ul Hussan Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Mubashir Kabir Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Iftikhar Ali Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Muhammad Sajjad Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Ayesha Sadaf Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Javeria Mukhtar Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Faiza Hassan Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan

DOI :

https://doi.org/10.53576/bashir.003.01.0044

Mots-clés :

Covid-19, siRNA, SARS-CoV-2, proteolytic enzymes, open reading frames, viral RNA-polymerase

Résumé

Not attempted because its a short commentary.

Téléchargements

Publiée

2022-12-12

Numéro

Vol. 3 No 1 (2022): J. Bashir Inst. Health Sci.

Rubrique

Commentry